NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
Title:
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
Author:
Wainberg, Zev A Melisi, Davide Macarulla, Teresa Pazo Cid, Roberto Chandana, Sreenivasa R De La Fouchardière, Christelle Dean, Andrew Kiss, Igor Lee, Woo Jin Goetze, Thorsten O Van Cutsem, Eric Paulson, A Scott Bekaii-Saab, Tanios Pant, Shubham Hubner, Richard A Xiao, Zhimin Chen, Huanyu Benzaghou, Fawzi O'Reilly, Eileen M
Appeared in:
Lancet
Paging:
Volume 402 () nr. 10409 pages 1272-1281
Year:
2023
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license